Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry

OBJECTIVE: To retrospectively evaluate the 12-month effectiveness of the Endeavor zotarolimus-eluting stent (ZES) in diabetic versus non-diabetic patients enrolled in the E-Five Registry. DESIGN AND SETTING: The E-Five Registry is a prospective, multicentre registry of 8314 patients presenting with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Ajay K, Lotan, Chaim, Meredith, Ian T, Feres, Faustos, Zambahari, Robaayah, Sinha, Nakul, Rothman, Martin T
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Interventional Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921264/
https://www.ncbi.nlm.nih.gov/pubmed/20478863
http://dx.doi.org/10.1136/hrt.2009.184150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921264/
https://www.ncbi.nlm.nih.gov/pubmed/20478863
http://dx.doi.org/10.1136/hrt.2009.184150

Ejemplares similares